LUND, S.E., February 9, 2026 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has achieved a “B” score in the 2025 CDP Climate Change assessment, improving from a “C” in 2024. The result reflects strengthened environmental management practices and continued progress in how the company identifies, manages, and acts on climate-related impacts, risks, and opportunities.
“This CDP result signals a shift from awareness to more coordinated, structured climate action. Through stronger climate oversight and embedding sustainability into our business strategy, we are better positioned to manage risk, support our customers, and contribute to responsible innovation across clinical research and the life sciences sector.” – Markus Granlund, Chief Executive Officer
Compared with last year, TFS demonstrated notable advancements across several strategic areas assessed by CDP, including leadership-level performance in public policy engagement and industry collaboration, climate context, risk disclosure, and the identification of climate-related dependencies, impacts, risks, and opportunities. These improvements are underpinned by strengthened governance and environmental policies that support clearer accountability, alongside continued advancement in value chain engagement and the management of Scope 3 emissions—critical focus areas for a global CRO.
“CDP provides a valuable external lens on how effectively we translate climate ambition into action. Our 2025 score shows real progress, but also highlights where we need to continue strengthening execution, data quality, and transparency as our climate agenda matures. Building on this foundation, we have ambitious plans for the year ahead, strengthening what already works, exploring new opportunities, and delivering lasting, positive outcomes for our stakeholders, while keeping a just transition at the center of our approach.” – Nicole Bezuidenhout, Sustainability & Communications Manager
These results mark a pivotal moment for TFS as the company advances its sustainability strategy, including recently validated science-based targets and closer alignment with evolving regulatory and stakeholder expectations, such as CSRD and ESRS. This milestone also aligns with the broader sustainability priorities and approach of TFS’s owner, Ratos AB, for climate transparency, risk management, and long-term value creation.
For pharmaceutical and biotechnology sponsors, this means partnering with a CRO that proactively integrates climate-related risk and opportunity management into its operations and value chain, supporting more resilient clinical trials, responsible sourcing, and greater transparency across global supply networks. At the same time, it contributes to a broader commitment to delivering high-quality, innovative research in a way that considers lasting environmental and societal value, reinforcing responsible business practices that benefit patients, employees, and partners.
“A CDP score is a sign of commitment to high-quality data that enables companies to take earth-positive economic decisions that future-proof their operations, improving access to capital, competitiveness and compliance. Tackling environmental risks head-on will create a more resilient economy and increase companies’ ability to innovate and invest. We look forward to seeing all companies build on their accolade and turn their commitments into meaningful and effective action.” Sherry Madera, CEO of CDP
TFS continues to build the foundations for robust, science-aligned climate action, strengthening how sustainability is embedded across strategy, operations, and culture, while remaining transparent about both achievements and areas for continued improvement.
About TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic partners provide tailored strategic resourcing solutions and clinical development services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.
For more information, visit www.tfscro.com.
About CDP
CDP is a global non-profit that runs the world’s only independent environmental disclosure system. As the founder of environmental reporting, we believe in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, we surface the information needed to enable Earth-positive decisions. We helped more than 24,800 companies and almost 1,000 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world’s institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB’s climate standard, IFRS S2, as its foundational baseline, CDP integrates best practice reporting standards and frameworks in one place. Our team is truly global, united by our shared desire to build a world where people, planet and profit are truly balanced. Visit cdp.net or follow @CDP to find out more.